3 reports

HE ALSO HOLDS AN MCHEM IN CHEMISTRY WITH MEDICINAL CHEMISTRY FROM THE UNIVERSITY OF NEWCASTLE UPON TYNE WHERE HE STUDIED CELLULAR DRUG DELIVERY SYSTEMS AND THE EFFECT OF THE ANTITUMOR AGENT APOPTIN.

  • Immunotherapy
  • Australasia
  • Oceania
  • Merck & Co., Inc.
  • Novartis AG

All trial arms used the same nasal spray delivery system.

  • Allergy Drug
  • Allergy Immunotherapy
  • Immunotherapy
  • Australasia
  • Product Initiative

The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatment of cancer and inflammatory diseases.

  • Hospital
  • Immunotherapy
  • Pharmaceutical
  • Australasia
  • Product Initiative